Marshall Wace, LLP Relay Therapeutics, Inc. Transaction History

Marshall Wace, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$20.26 - $32.36 $50,629 - $80,867	-2,499 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$26.0 - $37.03 $448,006 - $638,063	-17,231 Reduced 87.33%	2,499 $77,000
Q3 2021 Nov 15, 2021	SELL	$29.75 - $37.99 $2.06 Million - $2.63 Million	-69,101 Reduced 77.79%	19,730 $622,000
Q2 2021 Aug 13, 2021	BUY	$27.5 - $38.19 $2.17 Million - $3.01 Million	78,729 Added 779.34%	88,831 $3.25 Million
Q1 2021 May 17, 2021	BUY	$32.52 - $61.53 $328,517 - $621,576	10,102 New	10,102 $349,000

187

127M

4.2K

1.7K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $834M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.